Key Takeaways Shares of AEHR declined 9.1% to close at $132.37 during Tuesday’s session, accompanied by significantly reduced trading volume Wall Street analysts maintain a consensus “Buy” re
Shares of Aehr Test Systems (AEHR) experienced a significant decline on Tuesday, falling 9.1% to reach $132.37 during midday trading hours. This represents a notable pullback from the prior session’s closing price of $145.61.
Trading activity remained subdued throughout the session. Approximately 520,330 shares were traded, marking a substantial 79% decline compared to the typical daily trading volume of 2,424,321 shares.
The stock’s 12-month trading pattern reveals considerable volatility. Over the past year, AEHR reached a bottom of $16.38 and climbed to a peak of $147.40, which was achieved in recent trading sessions.
At prevailing prices, the semiconductor testing equipment manufacturer commands a market capitalization of approximately $4.03 billion. The company shows a price-to-earnings ratio of -519.12, while its beta coefficient of 3.10 indicates substantial historical volatility relative to the broader market.
The recent price decline hasn’t dampened analyst enthusiasm for AEHR. The stock maintains a collective “Buy” recommendation from Wall Street analysts, who have established a consensus price objective of $136.67.
In a notable development this week, Jefferies launched coverage of the stock with a “Buy” recommendation alongside an aggressive $175 price target, positioning it among the most optimistic forecasts currently available.
Both Freedom Capital and Zacks Research elevated their recommendations to “Strong Buy” during July. Meanwhile, Wall Street Zen revised its stance from “Sell” to “Hold” during the same timeframe.
Craig Hallum maintained its positive outlook in July, reiterating a “Buy” rating with a $125 price objective. Conversely, Weiss Ratings took a more pessimistic view, lowering its assessment from “Sell (D)” to “Sell (E+)” in late July.
Among the seven analysts providing coverage, the breakdown includes two “Strong Buy” recommendations, four “Buy” ratings, and one “Sell” rating.
Recent insider transactions have attracted considerable market attention. During the past three months, company insiders have collectively divested 109,475 shares valued at approximately $13.8 million.
Chief Operating Officer Adil Engineer disposed of 15,000 shares on August 12 at an average transaction price of $131.02, generating proceeds of $1.97 million. This sale reduced his ownership stake by 24.2%.
Executive Vice President Alberto Salamone sold 9,672 shares on August 13 at a price of $127.72 per share, yielding approximately $1.24 million. His holdings decreased by 18.7% following this transaction.
Board Director Howard T. Slayen divested 20,000 shares on August 4 at $108.30 each, completing a transaction valued at $2.17 million. This sale trimmed his position by roughly 12%.
Company insiders currently maintain ownership of 6.8% of total outstanding shares.
Among institutional investors, Royal Bank of Canada expanded its position by 15.3% during the first quarter, purchasing 7,968 additional shares to reach a total holding of 59,939. Vanguard increased its stake by 2.2%, while UBS significantly expanded its position by 55.7%. Institutional investment firms collectively control 69.69% of the company’s shares.
Technical indicators show the 50-day moving average at $93.83 and the 200-day moving average at $72.59, both trading substantially below the current share price.
The post Aehr Test Systems (AEHR) Stock Tumbles 9% Amid $13.8M Insider Share Dump appeared first on Blockonomi.
